Literature DB >> 1851541

Angiotensin II generation in the rat vena cava: stimulation of local synthesis by beta-adrenoceptor activation.

J Ziogas1, D F Story.   

Abstract

There is considerable evidence to suggest that isolated tissues have the capacity to generate angiotensin II and that angiotensin II thus generated may enhance noradrenergic neurotransmission. In the present study the possibility that there may be local formation of angiotensin II within the rat vena cava and its consequence to noradrenergic transmission has been investigated. The angiotensin II precursors, angiotensin I and a synthetic tetradecapeptide renin substrate, each enhanced the stimulation-induced efflux of radioactivity from tissues previously incubated with 3H-noradrenaline. The effects of angiotensin I were blocked by the converting enzyme inhibitor captopril and the receptor antagonist saralasin, indicating local conversion to angiotensin II. The effect of the tetradecapeptide was blocked by saralasin, but not by captopril, suggesting either a direct effect of this peptide or conversion to angiotensin II by a pathway not involving angiotensin converting enzyme. The beta-adrenoceptor agonist isoprenaline enhanced noradrenergic transmission in the rat vena cava, relaxed guinea-pig trachea precontracted with carbachol and increased heart rate in rat isolated atria. Captopril and saralasin blocked the effect of isoprenaline in the vena cava, but did not alter its effects in the atria or trachea. This suggests that in the rat vena cava the facilitation of noradrenergic transmission by isoprenaline may involve stimulation of local angiotensin II production.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1851541     DOI: 10.1007/bf00180673

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  21 in total

Review 1.  The site of angiotensin production.

Authors:  D J Campbell
Journal:  J Hypertens       Date:  1985-06       Impact factor: 4.844

2.  Vascular renin-angiotensin: a possible autocrine or paracrine system in control of vascular function.

Authors:  V J Dzau
Journal:  J Cardiovasc Pharmacol       Date:  1984       Impact factor: 3.105

3.  The zig-zag tracheal strip.

Authors:  J Emmerson; D Mackay
Journal:  J Pharm Pharmacol       Date:  1979-11       Impact factor: 3.765

4.  Facilitation of adrenergic transmission by locally generated angiotensin II in rat mesenteric arteries.

Authors:  K U Malik; A Nasjletti
Journal:  Circ Res       Date:  1976-01       Impact factor: 17.367

5.  Subendothelial beta 2-adrenoceptors in the rat vena cava: facilitation of noradrenaline release via local stimulation of angiotensin II synthesis.

Authors:  M Göthert; P Kollecker
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-10       Impact factor: 3.000

6.  Beta-adrenoceptor-mediated release of angiotensin II from mesenteric arteries.

Authors:  M Nakamaru; E K Jackson; T Inagami
Journal:  Am J Physiol       Date:  1986-01

7.  Isorenin, pseudorenin, cathepsin D and renin. A comparative enzymatic study of angiotensin-forming enzymes.

Authors:  E Hackenthal; R Hackenthal; U Hilgenfeldt
Journal:  Biochim Biophys Acta       Date:  1978-02-10

8.  Effect of locally generated angiotensin II on noradrenergic neuroeffector function in the rat isolated caudal artery.

Authors:  J Ziogas; D F Story
Journal:  J Hypertens Suppl       Date:  1987-07

Review 9.  Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors.

Authors:  H Majewski
Journal:  J Auton Pharmacol       Date:  1983-03

Review 10.  Presynaptic beta-adrenoceptors.

Authors:  Y Misu; T Kubo
Journal:  Med Res Rev       Date:  1986 Apr-Jun       Impact factor: 12.944

View more
  1 in total

1.  Facilitation by procaterol, a beta-adrenoceptor agonist, of noradrenaline release in the pithed rat independently of angiotensin II formation.

Authors:  P Kotsonis; H Majewski
Journal:  Br J Pharmacol       Date:  1994-11       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.